Literature DB >> 36099139

Squamous or Glandular Differentiation Predicts Poor Prognosis in pT1 Urothelial Carcinoma.

Ryunosuke Nakagawa1, Hiroaki Iwamoto2, Tomoyuki Makino3, Suguru Kadomoto1, Hiroshi Yaegashi1, Kazuyoshi Shigehara1, Kouji Izumi1, Yoshifumi Kadono1, Atsushi Mizokami1.   

Abstract

BACKGROUND: The aim of this study was to evaluate the prognosis of patients with T1N0M0 urothelial carcinoma with squamous differentiation (UCSD) or glandular differentiation (UCGD) because it has not been determined whether these variant histologies behave more aggressively than pure urothelial carcinoma (PUC). PATIENTS AND METHODS: Ninety-nine patients diagnosed with pT1N0M0 bladder cancer and treated conservatively with transurethral resection of bladder tumor at Kanazawa University Hospital between 2007 and 2019 were included in this study. The overall survival, cancer-specific survival (CSS), and recurrence-free survival of the variant histology and PUC groups were evaluated and compared.
RESULTS: The variant histology group had significantly lower overall survival (p=0.006) and CSS (p=0.0095) than the PUC group did. Variant histology was found to be an independent prognostic factor in univariate and multivariate analyses for overall survival and CSS. On the other hand, no significant difference in progression-free survival was observed between the two groups (p=0.439). However, the variant histology group had significantly lower overall survival (p=0.004) and CSS (p=0.004) after progression.
CONCLUSION: The prognosis for patients with pT1 bladder cancer with UCSD or UCGD treated conservatively with transurethral resection of bladder tumor was poor. Considering the worse prognosis of these patients after stage progression, early radical cystectomy could be recommended.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Urothelial carcinoma; glandular differentiation; non-muscle-invasive bladder cancer; squamous differentiation

Mesh:

Year:  2022        PMID: 36099139      PMCID: PMC9463927          DOI: 10.21873/invivo.12968

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.406


  17 in total

1.  Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.

Authors:  Anirban P Mitra; Claudia C Bartsch; Georg Bartsch; Gus Miranda; Eila C Skinner; Siamak Daneshmand
Journal:  Urol Oncol       Date:  2013-03-07       Impact factor: 3.498

2.  Significance of Perioperative Chemotherapy in Squamous Cell Carcinoma of the Upper and Lower Urinary Tract.

Authors:  Tomoyuki Makino; Kouji Izumi; Ariunbold Natsagdorj; Hiroaki Iwamoto; Suguru Kadomoto; Renato Naito; Yoshifumi Kadono; Atsushi Mizokami
Journal:  Anticancer Res       Date:  2018-04       Impact factor: 2.480

3.  The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.

Authors:  Simon P Kim; Igor Frank; John C Cheville; R Houston Thompson; Christopher J Weight; Prabin Thapa; Stephen A Boorjian
Journal:  J Urol       Date:  2012-06-14       Impact factor: 7.450

4.  Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

Authors:  H W Herr; P C Sogani
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

5.  Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).

Authors:  Emil Scosyrev; Benjamin W Ely; Edward M Messing; V O Speights; H Barton Grossman; David P Wood; Ralph W de Vere White; Nicholas J Vogelzang; Donald L Trump; Ronald B Natale; Catherine M Tangen; E David Crawford; Ian M Thompson
Journal:  BJU Int       Date:  2010-11-24       Impact factor: 5.588

6.  The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy.

Authors:  Efstathios Kastritis; Meletios-Athanasios Dimopoulos; Nikolaos Antoniou; Charalambos Deliveliotis; Michael Chrisofos; Andreas Skolarikos; Dimitra Gika; Aristotle Bamias
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

7.  The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.

Authors:  Alberto A Antunes; Luciano J Nesrallah; Marcos F Dall'Oglio; Carlos E Maluf; Cesar Camara; Katia R Leite; Miguel Srougi
Journal:  Int Braz J Urol       Date:  2007 May-Jun       Impact factor: 1.541

8.  The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer.

Authors:  Ofer N Gofrit; Vladimir Yutkin; Amos Shapiro; Galina Pizov; Kevin C Zorn; Guy Hidas; Ilan Gielchinsky; Mordechai Duvdevani; Ezekiel H Landau; Dov Pode
Journal:  Front Oncol       Date:  2016-03-15       Impact factor: 6.244

9.  Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder.

Authors:  Hao Xu; Linguo Xie; Xiaoteng Liu; Yu Zhang; Zhonghua Shen; Tao Chen; Xiaoyu Qiu; Nan Sha; Chen Xing; Zhouliang Wu; Hailong Hu; Changli Wu
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

10.  Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis.

Authors:  Guobin Zhao; Chao Wang; Yuhong Tang; Xin Liu; Zihao Liu; Gang Li; Yanhui Mei
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.